ALPINE: Maintenance Letrozole/Abemaciclib

NCT06366347 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

32

Enrollment

OTHER

Sponsor class

Conditions

Endometrial Cancer
Recurrent Endometrial Cancer
TP53

Interventions

DRUG: Abemaciclib
DRUG: Letrozole
DRUG: Pembrolizumab

Sponsor

Dana-Farber Cancer Institute

Collaborators

[object Object]